The Joint Corp reports Q4 revenue up 14%, 2025 guidance for lower EBITDA

JOINT Corp

Q4 revenue from continuing operations $14.4M (+14% YoY); net income $986k vs loss $10.2M.
System-wide sales $145.2M (+9% Q4), comp sales 6%. Full-year sales $530.3M (+9%).
2025 guidance: system-wide sales $550-570M, consolidated adj EBITDA $10-11.5M vs $11.4M in 2024.
New franchised clinic openings expected 30-40 in 2025 vs 57 in 2024; refranchising of corp clinics ongoing.
Comp plan amended: CEO STIP max up to 125% base salary if EBITDA exceeds budget; CFO up to 62.5%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.